— Know what they know.
Not Investment Advice

ALMS NASDAQ

Alumis Inc.
1W: -0.9% 1M: -7.3% 3M: -74.8% YTD: -25.9% 1Y: +47.2%
$6.64
+0.13 (+2.00%)
 
Weekly Expected Move ±8.0%
$6 $6 $7 $7 $8
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 37 · $859.4M mcap · 91M float · 2.51% daily turnover · Short 43% of daily vol
Credit Risk of going bust: higher than 83% of companies Debt: 4.1% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the second-riskiest tenth, about 1 in 87 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.07 (down 99%), Alumis Inc. would be worth roughly what it owes.
Total debt $36.4M against a stock market value of $859.4M.
Distance to default 2.38 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $18.2M (short-term plus half of long-term), stock volatility 132.1%; Altman Z'' -2.45. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Supply Chain Overview

6 relationships
6
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2024-07-03
Earliest Filing
2025-05-21
Latest Filing
target: 3 partner: 1 acquirer: 1 investor: 1

Counterparties (Filed by ALMS)

6 relationships

Companies named in ALMS's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
ACELYRIN, Inc. — target Target company in the merger agreement with Alumis Inc. 2025-05-21 View
Arrow Merger Sub, Inc. — partner Wholly owned subsidiary of Alumis Inc. used as the merger vehicle. 2025-05-21 View
ACELYRIN, Inc. — target Target company in the proposed merger with Alumis Inc. 2025-04-21 View
ACELYRIN, Inc. — target Target company in the merger agreement with Alumis Inc. 2025-02-06 View
Arrow Merger Sub, Inc. — acquirer Wholly owned subsidiary of Alumis Inc. entering the merger agreement. 2025-02-06 View
AyurMaya Capital Management Fund, LP — investor Agreed to purchase 2,500,000 shares of Alumis Inc. common stock for $40.0 million. 2024-07-03 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-09-01 Other Events; Exhibits View
2026-08-13 Earnings Release; Exhibits View
2026-08-10 Other Events; Exhibits View
2026-07-02 Shareholder Vote View
2026-06-29 Other Events; Exhibits View
2026-05-14 Earnings Release; Exhibits View
2026-03-30 Other Events; Exhibits View
2026-03-19 Earnings Release; Exhibits View
2026-01-09 Results of Operations and Financial Condition; Other Events; Financial Statements and Exhibits View
2026-01-06 Other Events; Financial Statements and Exhibits View
2026-01-02 Other Events View
2025-11-13 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-09-03 Other Events; Financial Statements and Exhibits View
2025-08-13 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-08-04 Submission of Matters to a Vote of Security Holders View
2025-06-30 Financial Statements and Exhibits View
2025-05-21 Completion of Acquisition or Disposition of Assets; Departure/Election of Directors; Appointment of Acquisition View
2025-05-19 Submission of Matters to a Vote of Security Holders View
2025-05-14 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-04-21 Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits Agreement View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms